1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Cell Expansion Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Cell Expansion Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Ascension of Regenerative Medicine Industry will Increase the Use of Cell Expansion Technology
5.2 Market Opportunities
- 5.2.1 Significantly Growing Research in Drug Discovery Activities
5.3 Future Trends
- 5.3.1 Developments in the Middle-Income Countries Bring Opportunities To Launch Novel Products
5.4 Impact of Drivers and Restraints
6. North America Cell Expansion Market Regional Analysis
6.1 North America Cell Expansion Market Overview
6.2 North America Cell Expansion Market Revenue 2017-2027 (US$ Million)
6.3 North America Cell Expansion Market Forecast Analysis
7. North America Cell Expansion Market Analysis – by Product
7.1 Consumables and Instruments
- 7.1.1 Overview
- 7.1.2 Consumables and Instruments: North America Cell Expansion Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Cell Expansion Market Analysis – by Cell Type
8.1 Human Cell and Animal Cell
- 8.1.1 Overview
- 8.1.2 Human Cell and Animal Cell: North America Cell Expansion Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Cell Expansion Market Analysis – by Application
9.1 Regenerative Medicine & Stem Cell Research
- 9.1.1 Overview
- 9.1.2 Human Cell and Animal Cell: North America Cell Expansion Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Cancer and Cell-based Research
- 9.2.1 Overview
- 9.2.2 Human Cell and Animal Cell: North America Cell Expansion Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Other Applications
- 9.3.1 Overview
- 9.3.2 Human Cell and Animal Cell: North America Cell Expansion Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Cell Expansion Market – North America Analysis
10.1 North America
- 10.1.1 North America Cell Expansion Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Cell Expansion Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Cell Expansion Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Cell Expansion Market Breakdown, by Product
- 10.1.1.1.2 US: North America Cell Expansion Market Breakdown, by Cell Type
- 10.1.1.1.3 US: North America Cell Expansion Market Breakdown, by Application
- 10.1.1.2 Canada:
North America Cell Expansion Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Cell Expansion Market Breakdown, by Product
- 10.1.1.2.2 Canada: North America Cell Expansion Market Breakdown, by Cell Type
- 10.1.1.2.3 Canada: North America Cell Expansion Market Breakdown, by Application
- 10.1.1.3 Mexico :
North America Cell Expansion Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Cell Expansion Market Breakdown, by Product
- 10.1.1.3.2 Mexico : North America Cell Expansion Market Breakdown, by Cell Type
- 10.1.1.3.3 Mexico : North America Cell Expansion Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Cell Expansion Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 BD
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Merck KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Thermo Fisher Scientific, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Terumo Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 General Electric Company
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Corning Incorporated
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Miltenyi Biotec
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Danaher
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Lonza
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 STEMCELL TECHNOLOGIES, INC.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights